Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...

NHS patients in England with newly-diagnosed multiple myeloma can be treated with Celgene’s Revlimid as maintenance therapy after a stem cell transplant, after new guidance from NICE.

Celgene has been having some problems developing new drugs, but its Revlimid is the world’s best selling cancer drug – and the company is preparing to build on this with a filing in the new year.

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund.

In this piece, we will look at the stocks Jim Cramer recently discussed.

Revlimid, the big-selling multiple myeloma drug acquired in Bristol’s buyout of Celgene, will face a new slate of generics in March and then a full generic market in 2026, Boerner said.

Meanwhile, BMS sells CAR T therapy Abecma alongside three immunomodulators, Revlimid, Thalomid and Pomalyst, a portfolio it scooped up in its $74 billion buyout of Celgene in 2019. It also markets ...

Am J Health Syst Pharm. 2007;64(17):1799-1807. Despite a similar chemical structure to thalidomide, the toxicity profile of lenalidomide has been shown to be quite different. The major dose ...